Case-Control Study of Telavancin as an Alternative Treatment for Gram-Positive Bloodstream Infections in Patients with Cancer

Gram-positive bacterial infections are an important cause of morbidity and death among cancer patients, despite current therapy. In this case-control study, we evaluated the clinical outcomes and safety of telavancin in cancer patients with uncomplicated Gram-positive bloodstream infections (BSIs)....

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Antimicrob Agents Chemother
Hlavní autoři: Chaftari, Anne-Marie, Hachem, Ray, Jordan, Mary, Garoge, Kumait, Al Hamal, Zainab, El Zakhem, Aline, Viola, George M., Granwehr, Bruno, Mulanovich, Victor, Gagel, Andrew, Reitzel, Ruth, Yousif, Ammar, Jiang, Ying, Raad, Issam
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society for Microbiology 2015
Témata:
Clinical Therapeutics
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4704239/
https://ncbi.nlm.nih.gov/pubmed/26482312
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00617-15
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky